Ryan Gursky, DO
Orthopaedic Surgery · Tulsa, OKNPI 1366581068
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $17,538 of the $20,924 with a category attached, or 83.8%. Globus Medical accounts for 97.3% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2021 at $16,408 and has fallen 99.6% since, to $73 in 2025.
Across 47 payments — averaging $445.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Globus Medical$20K
- Takeda Pharmaceuticals U.S.A., Inc.$135
- Intercept Pharmaceuticals, Inc.$122
- Johnson & Johnson$111
- Biocomposites Inc$51
- Innovation Technologies Inc$37
- plus $118 from 6 others
What the payments were for
- Royalty or licence$1,4047%
- Consulting fees$17,53884%
- Travel & lodging$1,3877%
- Food & beverage$5953%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Globus Medical | 18 | $20,350 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $135 |
| Intercept Pharmaceuticals, Inc. | 9 | $122 |
| Johnson & Johnson(3 entities) | 5 | $111 |
| Biocomposites Inc | 1 | $51 |
| Innovation Technologies Inc | 1 | $37 |
| Baxter Healthcare | 1 | $31 |
| Davol Inc. | 1 | $28 |
| Pacira Therapeutics, Inc. | 1 | $21 |
| Zyla Life Sciences, Inc. | 1 | $15 |
| Amgen | 1 | $12 |
| Bioventus LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Acetabular Shell-Dual Mobility$8,707
- Joint Arthoplasty$7,558
- Provident$1,575
- Onvoy$1,404
- Joint$1,000
How this compares
$20,924 in reported general payments places this provider in the 80th percentile of 263 orthopaedic surgery providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 399 | $6,213 |
| Celecoxib | 93 | $1,956 |
| Meloxicam | 208 | $1,381 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 116 | $1,299 |
| Methylprednisolone | 42 | $323 |
| Tramadol Hcl | 65 | $300 |
| Cephalexin | 59 | $201 |
| Amoxicillin | 190 | $164 |
| Ondansetron OdtOndansetron | 15 | $134 |
| Ondansetron Hcl | 24 | $120 |
| Ciprofloxacin Hcl | 23 | $113 |
| Oxycodone Hcl | 20 | $105 |
| Cyclobenzaprine Hcl | 21 | $75 |
| Clindamycin Hcl | 16 | $26 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Tulsa
- Yogesh MittalTulsa$6.6M
- Brian ChalkinTulsa$183K
- Kasra AhmadiniaTulsa$138K
- Sarat KunapuliTulsa$136K
- Keivan AbtahiTulsa$77K
- Rodney PlasterTulsa$61K
- Garrett WallerTulsa$52K
- Landon StallingsTulsa$46K
- Travis SmallTulsa$39K
- Blake ShockleyTulsa$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.